Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Belimumab With Rituximab for Primary Membranous Nephropathy
- Status
- RECRUITING
- Phase
- PHASE2
Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study
- Status
- WITHDRAWN
- Phase
- PHASE4
Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity
- Status
- COMPLETED
- Phase
- PHASE2
RSV Study in Adults 60 to 75 Years of Age
- Status
- COMPLETED
- Phase
- NA
Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Education and Respiratory Rehabilitation on Quality of Life in COPD Patients
- Status
- UNKNOWN
- Phase
- NA
A 2-year, European Multicentre Study to Describe, Validate, and Predict Phenotypes of Knee Osteoarthritis
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa
- Status
- COMPLETED
- Phase
- N/A
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
- Status
- RECRUITING
- Phase
- PHASE2
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH
- Status
- UNKNOWN
- Phase
- NA
A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments
- Status
- COMPLETED
- Phase
- PHASE1
ARTHR-IS (Arthroplasties' Infections Due to Staphylococcus Aureus)
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults
- Status
- COMPLETED
- Phase
- PHASE2